DFTX Stock-Based Compensation
Definium Therapeutics Inc · Stock-Based Compensation
DFTX Stock-Based Compensation
Latest reported$9.64Mperiod ending
DFTX Quarterly Stock-Based Comp ($0.00 → $9.64M)
Quarterly stock-based compensation
High-resolution chart · PNG
DFTX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 9,639,000 | |
| 7,132,000 | |
| 11,417,000 | |
| 5,816,000 | |
| 5,253,000 | |
| 3,426,000 | |
| 3,445,000 | |
| 3,770,000 | |
| 5,430,000 | |
| 3,689,000 | |
| 3,676,000 | |
| 4,226,000 | |
| 3,842,000 | |
| 3,750,000 | |
| 1,376,000 | |
| 4,286,000 | |
| 4,253,000 | |
| 3,792,000 | |
| 11,039,000 | |
| 4,106,000 | |
| 32,988,000 | |
| 1,279,000 | |
| 5,114,032 | |
| 4,021,000 | |
| -2,144,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |